Patient enrollment ongoing in phase I/II study of DZD-9008 in NSCLC with EGFR or HER2 mutation July 26, 2019
Phase I trial of nivolumab, alone or in combination, for unresectable/recurrent biliary tract cancer July 26, 2019
Novel model of inflammatory enterocutaneous fistulas by transplantation of human fetal gut into mice July 26, 2019
Scynexis reaches SPA agreement with FDA on phase III study of ibrexafungerp to prevent recurrent VVC July 25, 2019
RSS